These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 564482)

  • 21. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
    Hawkey CJ; Newsom-Davis J; Vincent A
    J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):469-75. PubMed ID: 7276959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal myasthenia gravis in the infant of an asymptomatic thymectomized mother.
    Olanow CW; Lane RJ; Hull KL; Roses AD
    Can J Neurol Sci; 1982 May; 9(2):85-7. PubMed ID: 7104893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and immunological studies on a patient with myasthenia gravis before and after repeated plasma exchange].
    Gratwohl A; Cornu P; Speck B; Burri HP; Meili R; Kummer H; Fulpius B
    Schweiz Med Wochenschr; 1979 Nov; 109(44):1711-3. PubMed ID: 524104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
    Członkowski A; Członkowska A
    Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
    [No Abstract]   [Full Text] [Related]  

  • 28. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia.
    Vincent A
    J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholine receptor antibody in patients with myasthenia gravis.
    Xu XH; Zhu LP; Wu JY; Zhang SZ; Yang GZ; Ba T; Tan MX; Liu SL
    Asian Pac J Allergy Immunol; 1986 Dec; 4(2):101-5. PubMed ID: 3801096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient neonatal myasthenia gravis.
    Papazian O
    J Child Neurol; 1992 Apr; 7(2):135-41. PubMed ID: 1573230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intrathecal immunoactivation in the patients with myasthenia gravis--autoantibodies in the cerebrospinal fluid].
    Yamanaka N; Araki S
    Rinsho Shinkeigaku; 1989 Jan; 29(1):13-7. PubMed ID: 2743683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
    Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
    Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671.
    Voltz R; Hohlfeld R; Fateh-Moghadam A; Witt TN; Wick M; Reimers C; Siegele B; Wekerle H
    Neurology; 1991 Nov; 41(11):1836-8. PubMed ID: 1944918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of myasthenia gravis by immunoadsorption of plasma.
    Grob D; Simpson D; Mitsumoto H; Hoch B; Mokhtarian F; Bender A; Greenberg M; Koo A; Nakayama S
    Neurology; 1995 Feb; 45(2):338-44. PubMed ID: 7854536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.